New Dementia Treatments are on the Horizon
Two new treatments, Lecanemab and Donanemab, are currently being considered by the MHRA and they have the potential to significantly improve the outcomes of people with early diagnosis. The MHRA is expected to report back in the middle of the year.
Dementia
Parliament
Lecanemab
Donanemab